How to optimize lipid-lowering therapy for patients with higher CV risk?
22 Nov 2024
byDr. Chiu-Lai Fu, Specialist in Cardiology, Private Practice, Hong Kong
Dr
Chiu-Lai Fu reviews international guideline recommendations on LDL-C goals and
lipid-modifying therapy for patients at high or very high CV risk. Advantages
of ezetimibe/statin combination therapy are discussed based on clinical studies
and her experience.
